Giant Biogene Holding Co., Ltd. (HKG:2367)

Giant Biogene Holding Revenue

Giant Biogene Holding had revenue of 2.92B CNY in the half year ending June 30, 2026, with 14.85% growth. This brings the company's total for the last twelve months to 5.32B, down -12.89% year-over-year. In the year 2025, Giant Biogene Holding had annual revenue of 5.52B, down -0.37%. That makes Giant Biogene Holding the 8,771st largest company in the world by revenue and 549th in Hong Kong.

• Revenue (ttm): 5.32B CNY
• Revenue Growth: -12.89%
• P/S Ratio: 3.59
• Revenue / Employee: 2.30M CNY
• Employees: 2,319
• Market Cap: 22.04B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.52B	-20.30M	-0.37%
Dec 31, 2024	5.54B	2.01B	57.17%
Dec 31, 2023	3.52B	1.16B	49.05%
Dec 31, 2022	2.36B	811.96M	52.30%
Dec 31, 2021	1.55B	362.01M	30.41%

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 22, 2026

Data Sources Report a data error